Nonfusion does not prevent adjacent segment disease: Dynesys long-term outcomes with minimum five-year follow-up

GH St-Pierre, A Jack, MMA Siddiqui, RL Henderson… - Spine, 2016 - journals.lww.com
Study Design. Case series. Objective. The aim of this study was to determine the relationship
between fusion and adjacent segment disease via Dynesys long-term outcomes. Summary …

Ghrelin: a novel player in the gut-brain regulation of growth hormone and energy balance

DH St-Pierre, L Wang, Y Taché - Physiology, 2003 - journals.physiology.org
Ghrelin is a newly discovered peptide hormone produced by the stomach that displays potent
growth hormone-releasing activity and a stimulatory effect on food intake and digestive …

Adjacent segment pathology: progressive disease course or a product of iatrogenic fusion?

A Jack, GH St-Pierre, A Nataraj - Canadian Journal of Neurological …, 2017 - cambridge.org
Objective: Cervical spine clinical adjacent segment pathology (CASP) has a reported 3%
annual incidence and 26% ten-year prevalence. Its pathophysiology remains controversial, …

Performance indicators in spine surgery

GH St-Pierre, MH Yang, J Bourget-Murray, KC Thomas… - Spine, 2018 - journals.lww.com
Study Design. Systematic review. Objective. To elucidate how performance indicators are
currently used in spine surgery. Summary of Background Data. The Patient Protection and …

Pituitary abscess: review and highlight of a case mimicking pituitary apoplexy

GH St-Pierre, S de Ribaupierre… - Canadian journal of …, 2013 - cambridge.org
DISCUSSION Pituitary abscess is a very rare entity. Described in several surgical series of
pituitary disorders, the reported frequency is between 0.2-1% 1 with the three largest series …

Patient predictors of surgical candidacy in elective spine disorders

MMH Yang, GH St-Pierre, S DuPlessis - Canadian Journal of …, 2019 - cambridge.org
BackgroundThe expansion of age-related degenerative spine pathologies has led to
increased referrals to spine surgeons. However, the majority of patients referred for surgical …

Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans

A Benso, DH St-Pierre, F Prodam… - European Journal of …, 2012 - academic.oup.com
… In its acylated form, ghrelin displays a potent GH-releasing activity, mediated by the GH
secretagogue receptor type 1a (GHS-R1a) (4, 5), that is concentrated in central and peripheral …

Beta‐adrenergic agonism does not impair the GH response to acylated ghrelin in humans

…, B Lucatello, I Olivetti, D St Pierre… - Clinical …, 2009 - Wiley Online Library
… GHS because of their potent GH-releasing effect in vivo, well … GH secretion is still a matter
of debate. It is thought to be more likely to act as an amplifier of GH pulsatility than as a true GH

Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?

G Gourcerol, DH St-Pierre, Y Tache - Regulatory peptides, 2007 - Elsevier
… For instance, GPR39 is highly expressed in the pituitary [7], but obestatin injected iv influences
neither basal growth hormone (GH) nor ghrelin-stimulated GH release as monitored 10 …

Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women

DH St-Pierre, AD Karelis, L Coderre… - The Journal of …, 2007 - academic.oup.com
… Moreover, acylated ghrelin is the endogenous ligand of the GH secretagogue receptor 1a,
whereas recent reports indicate that nonacylated ghrelin may interact with another …